Here's what San Antonio doctors say about the widespread use of GLP-1 medications for obesity, diabetes and other conditions.

BLOCKBUSTER fat jabs that cost up to £200 a month could be sold for as little as £20 within just weeks. Semaglutide — the ...

A fascinating deep dive into the discovery, use and implications of a revolutionary new treatment ...

After tanking on Novo's "Wegovy Pill" release, Eli Lilly shares reversed course. See why investors may like its acquisition of Ventyx Biosciences.

BRITS will soon be able to get their hands on a triple strength dose of fat-blasting jab Wegovy, health chiefs have revealed.

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

A food-oil supplement called Elcella can work like a weight-loss jab, it has been claimed - but experts say more evidence is ...

GLP-1 drugs like Ozempic and Mounjaro have significant health benefits for type 1 diabetes, including weight loss, despite ...

Novo Nordisk is my top opportunity for 2026, driven by multiple catalysts and a compelling valuation. The Wegovy pill's FDA ...

The global diabetes injection pens market is projected to grow at a CAGR of approximately 7% through 2028. Market expansion ...

The collaboration will allow patients considering the oral GLP-1 therapy to access metabolic care through knownwell’s hybrid ...

Its newly earned indications could impact financial results in 2026. The drugmaker should also make decent pipeline progress. Novo Nordisk's shares look reasonably valued. Thankfully, 2026 could be a ...